Derive is running the XAUT Trading Competition through August 2026, rewarding the traders who post the best returns on Tether Gold (XAUT) options.
Trade XAUT options on Derive between 1 and 31 August 2026. To qualify, a trade must pay or receive at least $100 in option premium. Close the position or let it settle, then generate and share your official Derive PNL card.
Ranking is by realized PNL percentage. Only closed or settled positions count toward the leaderboard; open positions and unrealized gains are not eligible.
The top three traders each win an 8-gram pure gold Derive plate plus $500 in DRV.
Genuine market activity only. Wash trading, self-trading, coordinated activity, ranking manipulation, and altered PNL cards are prohibited, and Derive verifies every trade against its records and onchain data.
Entry to XAUT Trading Competition was free: there was no entry fee. Entrants only needed an account on Derive and to register inside the event.
XAUT Trading Competition ran from 2026-07-31 through 2026-08-30 (UTC), 30 days. The event has concluded; winners are listed above.
Derive did not require tournament-specific KYC for this event. Standard exchange-wide verification rules still applied to withdraw any prize won.
Total prize pool: $8,000. The prize ladder was published by Derive on the official tournament page.
The champions and final standings are listed in the results above on this page. The official archive on Derive is available at https://www.derive.xyz/xaut.
Affiliate disclosure:Links marked “Join on …” are referral links. We may earn a commission when you register and trade through them. It does not change the fees, terms, or eligibility offered to you by the exchange. See our full disclosure.
Risk: Trading crypto, futures, and options carries substantial risk of loss. Tournaments do not guarantee any returns. Do your own research before participating. See the risk disclaimer.
© 2026 trading-tournaments.com · Not financial advice.
The event on this page is over and Derive has nothing live at the moment. These three are taking entries now.